Transcript of NKarta (NKTX) CAR-NK Data for AML
Transcripts - Operator Thank you for standing by. Welcome to Nkarta Conference Call to review the clinical update for NKX101. At this time, all participants are in … Continue Reading
Read nowTranscripts - Operator Thank you for standing by. Welcome to Nkarta Conference Call to review the clinical update for NKX101. At this time, all participants are in … Continue Reading
Read nowTranscripts - Operator Ladies and gentlemen, thank you for standing by, and welcome to the Aldeyra Therapeutics conference call to present the positive Phase II results of … Continue Reading
Read nowTranscripts - Participants -Matt Gline, CEO -Mayukh, Sukhatme, President & CIO -Frank Torti, Chair Operator Good morning, ladies and gentlemen. Thank you for standing by. Welcome to … Continue Reading
Read nowTranscripts - Participants Richard Aranda, CMO Fahim Hasnain, CEO Bryan Giruado, CFO Fahim Hasnain, CEO We’re very excited about getting our phase three off the ground. We’re … Continue Reading
Read nowInsights - Day One (DAWN) announced a $150M raise priced at $13/share after presenting additional data at ASCO 2023. Importantly, the company formed a regulatory pathway in … Continue Reading
PremiumTranscripts - Webcast: https://player.vimeo.com/video/833811575?badge=0&autopause=0&player_id=0&app_id=58479%22 Participants William Doyle, Executive Chairman Ticiana Leal, Emory University Corey J Langer, University of Pennsylvania Pritesh Shah, Chief Growth Officer Ashley Cordova, Chief … Continue Reading
Read nowTranscripts - Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=VEzQVRmI Participants Frank Bedu-Addo, Chief Executive Officer Lauren V. Wood, Chief Medical Officer Matt Hill, Chief Financial Officer Frank Bedu-Addo, Chief Executive OfficerThanks for … Continue Reading
Read now